GregoryEBergerMDMHCM

PubMed

• Lithium suppression of tau induces brain iron accumulation and neurodegeneration.
  Lei P, Ayton S, Appukuttan AT, Moon S, Duce JA, Volitakis I, Cherny R, Wood SJ, Greenough M, Berger G, Pantelis C, McGorry P, Yung A, Finkelstein DI, Bush AI> ;Mol. Psychiatry. 2016-07-12
• 5 citations
  A Case of Septic Arthritis of the Wrist due to Finegoldia magna.
  Camelia Arsene, Abhijit Saste, Manya Somiah, Janee Mestrovich, Gregory Berger> ;Case Reports in Infectious Diseases. 2014 Apr 13
• 12 citations
  A case series of emphysematous pyelonephritis.
  Camelia Arsene, Abhijit Saste, Shankar Arul, Janee Mestrovich, Revark Kammo, Mohammed Elbashir, Gregory Berger> ;Case Reports in Medicine. 2014 Apr 9
• Omega-3 fatty acid supplementation changes intracellular phospholipase A2 activity and membrane fatty acid profiles in individuals at ultra-high risk for psychosis.
  Smesny S, Milleit B, Hipler U, Milleit C, Schäfer MR, Klier CM, Holub M, Holzer I, Berger GE, Otto M, Nenadic I, Berk M, McGorry PD, Sauer H, Amminger GP> ;Mol. Psychiatry. 2014-03-01
• The role of phospholipases A2 in schizophrenia.
  Law, M. H., Cotton, R. G., Berger, G. E.> ;Mol Psychiatry. 2006 Jun
• Pituitary volume and early treatment response in drug-naïve first-episode psychosis patients.
  Garner, B., Berger, G. E., Nicolo, J. P., Mackinnon, A., Wood, S. J., Pariante, C. M., Dazzan, P., Proffitt, T. M., Markulev, C., Kerr, M., McConchie, M., Phillips, L....> ;Schizophr Res. 2009 Aug 01
• Early-onset of symptoms predicts conversion to non-affective psychosis in ultra-high risk individuals.
  Amminger, G. P., Leicester, S., Yung, A. R., Phillips, L. J., Berger, G. E., Francey, S. M., Yuen, H. P., McGorry, P. D.> ;Schizophr Res. 2006 May
• Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis.
  Garner, B., Pariante, C. M., Wood, S. J., Velakoulis, D., Phillips, L., Soulsby, B., Brewer, W. J., Smith, D. J., Dazzan, P., Berger, G. E., Yung, A. R., van den Buuse...> ;Biol Psychiatry. 2005 Sep 1
• The transition to psychosis: risk factors and brain changes.
  Wood, S. J., Yücel, M., Yung, A. R., Berger, G. E., Velakoulis, D., Pantelis, C.> ;Epidemiol Psichiatr Soc. 2004 Nov 09
• Insight in relation to psychosocial adjustment in schizophrenia.
  Simon, A. E., Berger, G. E., Giacomini, V., Ferrero, F., Mohr, S.> ;J Nerv Ment Dis. 2004 Jun
• Incipient neurovulnerability and neuroprotection in early psychosis.
  Berger, G. E., Wood, S., McGorry, P. D.> ;Psychopharmacol Bull. 2003
• Implications of lipid biology for the pathogenesis of schizophrenia.
  Berger, G. E., Wood, S. J., Pantelis, C., Velakoulis, D., Wellard, R. M., McGorry, P. D.> ;Aust N Z J Psychiatry. 2002 Jun
• Neuroprotective Effects of Low-dose Lithium in Individuals at Ultra-high Risk for Psychosis. A Longitudinal MRI/MRS Study.
  Berger, G. E., Wood, S. J., Ross, M., Hamer, C. A., Wellard, R. M., Pell, G., Phillips, L., Nelson, B., Amminger, G. P., Yung, A. R., Jackson, G., Velakoulis, D., Pant...> ;Curr Pharm Des. 2012
• Relational memory in first episode psychosis: implications for progressive hippocampal dysfunction after illness onset.
  Bartholomeusz, C. F., Proffitt, T. M., Savage, G., Simpson, L., Markulev, C., Kerr, M., McConchie, M., McGorry, P. D., Pantelis, C., Berger, G. E., Wood, S. J.> ;Aust N Z J Psychiatry. 2011 Mar
• Phospholipase A₂ activity in first episode schizophrenia: associations with symptom severity and outcome at week 12.
  Smesny, S., Kunstmann, C., Kunstmann, S., Willhardt, I., Lasch, J., Yotter, R. A., Proffitt, T. M., Kerr, M., Marculev, C., Milleit, B., Milleit, C., Nenadic, I., Ammi...> ;World J Biol Psychiatry. 2011 Dec
• Pituitary volume increase during emerging psychosis.
  Büschlen, J., Berger, G. E., Borgwardt, S. J., Aston, J., Gschwandtner, U., Pflueger, M. O., Kuster, P., Radü, E. W., Stieglitz, R. D., Riecher-Rössler, A.> ;Schizophr Res. 2011 Jan
• Neuroprotective effects of ethyl-eicosapentaenoic acid in first episode psychosis: a longitudinal T2 relaxometry pilot study.
  Wood, S. J., Cocchi, L., Proffitt, T. M., McConchie, M., Jackson, G. D., Takahashi, T., Pantelis, C., McGorry, P. D., Berger, G. E.> ;Psychiatry Res. 2010 May 30
• Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.
  Amminger, G. P., Schäfer, M. R., Papageorgiou, K., Klier, C. M., Cotton, S. M., Harrigan, S. M., Mackinnon, A., McGorry, P. D., Berger, G. E.> ;Arch Gen Psychiatry. 2010 Feb
• Hippocampus abnormalities in at risk mental states for psychosis? A cross-sectional high resolution region of interest magnetic resonance imaging study.
  Buehlmann, E., Berger, G. E., Aston, J., Gschwandtner, U., Pflueger, M. O., Borgwardt, S. J., Radue, E. W., Riecher-Rössler, A.> ;J Psychiatr Res. 2010 May 01
• The effect of atypical antipsychotics on pituitary gland volume in patients with first-episode psychosis: a longitudinal MRI study.
  Nicolo, J. P., Berger, G. E., Garner, B. A., Velakoulis, D., Markulev, C., Kerr, M., McGorry, P. D., Proffitt, T. M., McConchie, M., Pantelis, C., Wood, S. J.> ;Schizophr Res. 2010 Jan 01
• Medial temporal lobe glutathione concentration in first episode psychosis: a 1H-MRS investigation.
  Wood, S. J., Berger, G. E., Wellard, R. M., Proffitt, T. M., McConchie, M., Berk, M., McGorry, P. D., Pantelis, C.> ;Neurobiol Dis. 2009 Mar 01
• The International Study on General Practitioners and Early Psychosis (IGPS).
  Simon, A. E., Lester, H., Tait, L., Stip, E., Roy, P., Conrad, G., Hunt, J., Epstein, I., Larsen, T. K., Amminger, P., Holub, D., Wenigová, B., Turner, M., Berger, G. ...> ;Schizophr Res. 2009 Mar 01
• Dosing quetiapine in drug-naive first-episode psychosis: a controlled, double-blind, randomized, single-center study investigating efficacy, tolerability, and safety o...
  Berger, G. E., Proffitt, T. M., McConchie, M., Kerr, M., Markulev, C., Yuen, H. P., O'Donnell, C., Lubman, D., Polari, A., Wood, S., Amminger, P. G., McGorry, P. D.> ;J Clin Psychiatry. 2008 Nov 01
• Adhesio interthalamica in individuals at high-risk for developing psychosis and patients with psychotic disorders.
  Takahashi, T., Yücel, M., Yung, A. R., Wood, S. J., Phillips, L. J., Berger, G. E., Ang, A., Soulsby, B., McGorry, P. D., Suzuki, M., Velakoulis, D., Pantelis, C.> ;Prog Neuropsychopharmacol Biol Psychiatry. 2008 Oct 1
• Pilot study evaluating the effect of massage therapy on stress, anxiety and aggression in a young adult psychiatric inpatient unit.
  Garner, B., Phillips, L. J., Schmidt, H. M., Markulev, C., O'Connor, J., Wood, S. J., Berger, G. E., Burnett, P., McGorry, P. D.> ;Aust N Z J Psychiatry. 2008 May
• Join now to see all